QIAGEN N.V. to Release Results for Q4 2025 and Hold Webcast

Company Overview - QIAGEN N.V. is a Netherlands-based holding company and a global leader in Sample to Insight solutions, enabling customers to extract and analyze molecular information from biological samples [3] - The company provides technologies for isolating and processing DNA, RNA, and proteins, as well as assay technologies for analysis and bioinformatics for data interpretation [3] - QIAGEN serves over 500,000 customers worldwide in Life Sciences and Molecular Diagnostics, employing approximately 5,700 people across more than 35 locations as of September 30, 2025 [3] Financial Announcement - QIAGEN plans to release its results for the fourth quarter of 2025 on February 4, 2026, shortly after 22:05 Frankfurt time [1] - A conference call will be held on February 5, 2026, at 15:30 Frankfurt time to discuss the results [1] Conference Call Details - Participants can join the conference call via three options: registering for a call back connection, dialing in by phone, or accessing the audio webcast [2] - Dial-in numbers include U.S.: +1 646 769 9200, UK: +44 (0)20 7769 6464, and Germany: +49 (0)69 254 99300, with a conference ID of 3382302 [2]